Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Bullboard Posts
Comment by tradingsteveon Jul 27, 2010 3:00pm
422 Views
Post# 17300860

RE: SSS - Strong Buy

RE: SSS - Strong Buyeasymoney........

we had a shot at a good discussion with the last post on here, then you do something like this......the 1 and only analyst on SSS was as confident pre-Phase II results, as they were post and same for last month when SSS announced that they still have no explanation for the Phase II results

I'd love to see the 6 month chart on that to confirm the one and only analyst, who oddly has a strong buy rating on it, is either not paying attention to SSS at all or has to be easymoney himself
Bullboard Posts